Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Natera, Inc. NTRA

Healthcare  —  Diagnostics & Research
412.56 3.77 0.92% as of 25 Sep
Market cap
$59.2B
P/E
0.0×
Cash Flow Champion (3y)
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending) TTM (Descending) TTM (Ascending)
Download Excel — free account
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio 2.89 2.41 3.13 7.75 20.62 13.52 4.62 6.58 11.63 13.58
P/FCF ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 285.13 287.05
P/Operating CF (20.69) (17.95) (63.03) (155.66) (109.99) (85.65) (46.69) (123.61) 373.30 423.90
P/B ratio 5.76 19.86 25.11 8.41 16.58 12.95 5.37 9.30 16.52 18.29
Price to Tangible BV 5.76 19.86 25.11 8.41 16.58 12.95 5.37 9.30 16.67 26.15
EV/Sales 2.53 2.43 3.00 6.70 19.38 12.59 3.96 6.10 11.28 13.27
EV/EBITDA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Operating CF (7.25) (5.20) (10.95) (31.93) (41.52) (23.49) (7.53) (26.75) 141.09 142.18
EV/FCF (5.52) (4.73) (10.38) (29.62) (37.49) (20.92) (6.78) (23.08) 276.45 280.55
Quick Ratio 1.67 1.54 1.94 2.75 4.10 4.73 3.68 3.77 3.73 3.11
Current Ratio 1.81 1.71 2.11 2.91 4.33 4.99 3.90 4.10 4.00 3.39
Net Debt/EBITDA 1.04 (0.03) 0.33 2.96 2.40 1.30 1.04 1.23 4.65 3.74
Debt/Assets 23.55% 57.39% 46.06% 21.24% 27.09% 26.72% 25.96% 25.20% 4.84% 3.35%
Debt/Equity 0.47 4.85 3.84 0.44 0.52 0.51 0.51 0.47 0.07 0.05
Asset Turnover 0.89 0.99 1.07 0.71 0.52 0.58 0.62 0.76 1.09 1.14
Operating CF/Net income 0.74 0.71 0.55 0.51 0.79 0.71 0.79 0.57 (0.71) (1.03)
Capex/Depreciation (3.04) (1.21) (0.48) (0.54) (1.35) (2.02) (2.09) (1.48) (2.45) (3.20)
Interest Coverage 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE (68.90%) (208.70%) (445.14%) (80.31%) (60.07%) (82.79%) (80.62%) (59.11%) (19.42%) (14.32%)
ROA (42.16%) (64.72%) (53.09%) (29.34%) (30.33%) (43.50%) (41.64%) (30.66%) (12.28%) (10.26%)
ROIC (710.26%) (285.12%) 0.00% 0.00% (10,224.90%) (422.60%) (199.67%) (111.70%) (45.18%) (27.03%)
Return on Tangible Assets (91.22%) (131.41%) (84.94%) (34.05%) (32.96%) (50.20%) (55.12%) (40.92%) (15.95%) (16.05%)
Average Days of Receivables 23.01 76.77 88.15 64.41 73.34 71.24 108.75 93.83 67.58 46.93
Research and Development Expense of Revenue 19.70% 23.88% 19.93% 16.99% 25.58% 42.24% 38.58% 29.62% 23.82% 27.06%
Selling, General and Administrative Expense of Revenue 64.06% 74.09% 60.11% 68.20% 77.65% 81.70% 71.76% 57.11% 49.58% 51.05%
Intangible Assets out of Total Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.21
Share Based Compensation of Revenue 4.99% 5.44% 5.51% 9.47% 12.83% 18.42% 18.58% 17.72% 16.17% 15.37%
Graham Net Nets 0.11 (0.02) 0.01 0.09 0.05 0.06 0.14 0.08 0.05 0.03
Graham Number 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Yield (15.56%) (27.24%) (15.97%) (5.37%) (2.82%) (5.54%) (14.47%) (6.12%) (0.97%) (0.67%)
Free Cash Flow Yield (15.85%) (21.33%) (9.22%) (2.92%) (2.51%) (4.45%) (12.65%) (4.02%) 0.35% 0.35%
Revenue per Share 4.12 3.93 4.45 4.35 4.83 6.91 8.33 9.41 13.61 16.87
Operating CF per Share (1.44) (1.83) (1.22) (0.91) (2.25) (3.70) (4.38) (2.15) 1.09 1.57
Capex per Share (0.45) (0.19) (0.07) (0.07) (0.24) (0.45) (0.48) (0.34) (0.62) (1.02)
Free Cash Flow per Share (1.88) (2.02) (1.29) (0.98) (2.49) (4.15) (4.87) (2.49) 0.47 0.56
Cash per Share 2.85 2.23 2.74 6.34 9.10 10.10 9.13 7.64 7.76 7.87
Shareholders Equity per Share 2.06 0.48 0.56 4.01 6.00 7.21 7.17 6.66 9.59 12.52
Interest Debt per Share 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share 2.06 0.48 0.56 4.01 6.00 7.21 7.17 6.66 9.59 12.52
Free Cash Flow (97.19) (107.69) (74.46) (68.41) (202.12) (376.27) (479.20) (286.15) 58.75 76.11
Working Capital 77.70 75.06 126.54 343.29 663.61 874.18 901.32 951.28 1,031.78 1,055.71
Capital Expenditures (23.14) (9.87) (3.88) (4.97) (19.60) (41.03) (47.70) (39.20) (76.92) (139.19)
Net Current Asset Value 69.91 (8.57) 4.51 219.22 416.75 509.96 523.09 582.18 910.51 811.01
EV/EBIT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capex to Sales 0.11 0.05 0.02 0.02 0.05 0.07 0.06 0.04 0.05 0.06
Net Profit Margin (47.21%) (65.65%) (49.74%) (41.29%) (58.76%) (75.42%) (66.79%) (40.16%) (11.22%) (9.03%)
Price to Operating Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets 0.24 0.27 0.33 0.39 0.44 0.31 0.25 0.24 0.19 0.18
Cash ROIC (35.06%) (47.66%) (30.22%) (10.28%) (14.62%) (21.11%) (26.65%) (17.84%) (1.18%) (0.90%)
Accounts Receivable Turnover 22.07 7.29 4.85 5.23 5.93 6.23 4.48 4.14 5.73 7.55
Accounts Payable Turnover 14.41 13.95 14.37 15.13 24.39 18.04 15.64 25.56 26.99 23.88
Inventory Turnover 18.69 18.12 14.68 13.48 12.56 13.57 14.64 15.49 15.76 14.36
Average Days of Payables 30.90 22.30 32.06 17.90 14.51 31.19 24.92 9.28 18.92 14.89
Days of Inventory on Hand 17.27 23.53 29.97 25.78 35.91 30.85 28.32 25.22 24.24 30.73
Average Receivables 9.63 28.74 53.16 57.79 65.96 100.32 183.23 261.34 296.23 305.35
Average Payables 9.41 10.00 11.56 11.60 8.35 17.65 29.18 23.07 24.96 34.04
Average Inventory 7.25 7.71 11.32 13.01 16.21 23.47 31.16 38.08 42.75 56.59
Average Assets 237.96 212.65 241.39 425.41 757.40 1,084.32 1,315.48 1,418.09 1,551.22 2,029.54
Average Common Equity 145.62 65.95 28.79 155.44 382.47 569.77 679.52 735.54 980.37 1,453.92

Fold the line items

Columns are period end dates